Chugai Pharmaceutical Co (JP:4519) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Chugai Pharmaceutical Co. has increased its full-year revenue and profit forecasts for 2024, citing stronger domestic and overseas sales, including higher exports to Roche. The company now expects revenue of ¥1,150.0 billion and core operating profit of ¥540.0 billion, both significantly up from previous estimates.
For further insights into JP:4519 stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money